Discussion: This publication focuses on generating clinical evidence regarding the effectiveness of the autumn 2023 COVID-19 vaccine dose in healthcare workers across seven European countries. The study involves a prospective cohort design to measure vaccine effectiveness against SARS-CoV-2 infection. The primary goal is to produce evidence characterizing the impact of vaccination on disease prevention, which aligns with the objectives of clinical evidence generation. The study does not focus on developing data standards, methodological research, or open-source tools, but rather on testing a clinical hypothesis and generating real-world evidence.

Final category: 4. Clinical evidence generation
